Moderna is a biopharmaceutical company that develops and commercializes mRNA-based therapeutics and vaccines using proprietary technology platforms. The company manufactures and sells vaccines for infectious diseases, including COVID-19 and RSV, along with a diversified pipeline of programs in oncology (including personalized neoantigen therapies), infectious disease vaccines, and rare genetic diseases. Revenue is generated from the sale of approved vaccines and future commercial applications of pipeline programs, supported by manufacturing capabilities across multiple geographies and underpinned by proprietary advances in mRNA science, lipid nanoparticle delivery technology, and scalable manufacturing processes.